Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BSGMNASDAQ:INBSNASDAQ:NURONYSEAMERICAN:VTAK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBSGMBioSig Technologies$0.92+9.5%$0.69$0.20▼$2.57$15.86M0.79221,621 shs963,311 shsINBSIntelligent Bio Solutions$1.29-0.8%$1.74$1.00▼$3.04$8.79M4.63549,829 shs50,961 shsNURONeuroMetrix$4.34-0.9%$4.40$2.66▼$4.73$8.94M1.8215,450 shs1,331 shsVTAKCatheter Precision$0.29+1.8%$0.35$0.24▼$8.40$2.56M-0.341.05 million shs77,449 shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBSGMBioSig Technologies0.00%+60.00%+55.93%-4.20%-32.85%INBSIntelligent Bio Solutions0.00%+8.40%-14.57%-8.51%-52.04%NURONeuroMetrix0.00%-1.45%-2.03%+3.09%-2.25%VTAKCatheter Precision0.00%-9.41%-18.30%-29.23%-94.70%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBSGMBioSig Technologies1.9243 of 5 stars3.50.00.00.02.40.80.6INBSIntelligent Bio Solutions0.3028 of 5 stars0.02.00.00.02.00.00.6NURONeuroMetrix0.4163 of 5 stars0.03.00.00.01.80.00.6VTAKCatheter Precision0.6518 of 5 stars0.03.00.00.00.90.81.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBSGMBioSig Technologies 3.00Buy$2.50171.74% UpsideINBSIntelligent Bio Solutions 0.00N/AN/AN/ANURONeuroMetrix 0.00N/AN/AN/AVTAKCatheter Precision 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VTAK, BSGM, NURO, and INBS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025BSGMBioSig TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$2.75 ➝ $2.50(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBSGMBioSig Technologies$40K396.41N/AN/A($0.33) per share-2.79INBSIntelligent Bio Solutions$3.03M2.90N/AN/A$0.80 per share1.61NURONeuroMetrix$3.03M2.95N/AN/A$13.18 per share0.33VTAKCatheter Precision$440K5.82N/AN/A$30.16 per share0.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBSGMBioSig Technologies-$29.04MN/A0.00N/AN/A-44,832.50%N/A-776.49%5/19/2025 (Estimated)INBSIntelligent Bio Solutions-$10.16MN/A0.003.69N/A-323.79%-146.03%-83.62%5/14/2025 (Estimated)NURONeuroMetrix-$6.53M-$4.59N/A∞N/A-203.71%-42.56%-39.26%5/21/2025 (Estimated)VTAKCatheter Precision-$70.57MN/A0.00N/AN/A-2,928.32%-69.90%-41.82%5/5/2025 (Estimated)Latest VTAK, BSGM, NURO, and INBS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2025N/ABSGMBioSig Technologies-$0.18N/AN/AN/AN/AN/A5/5/2025N/AVTAKCatheter Precision-$0.20N/AN/AN/A$0.31 millionN/A2/13/2025Q2 2025INBSIntelligent Bio SolutionsN/A-$0.50N/A-$0.50N/A$610.00 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBSGMBioSig TechnologiesN/AN/AN/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/ANURONeuroMetrixN/AN/AN/AN/AN/AVTAKCatheter PrecisionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBSGMBioSig TechnologiesN/A0.500.50INBSIntelligent Bio SolutionsN/A0.920.76NURONeuroMetrixN/A13.8812.70VTAKCatheter Precision0.120.660.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBSGMBioSig Technologies7.16%INBSIntelligent Bio Solutions32.97%NURONeuroMetrix19.40%VTAKCatheter Precision20.34%Insider OwnershipCompanyInsider OwnershipBSGMBioSig Technologies17.03%INBSIntelligent Bio Solutions0.28%NURONeuroMetrix7.30%VTAKCatheter Precision1.35%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBSGMBioSig Technologies5017.24 million14.30 millionNo DataINBSIntelligent Bio Solutions106.81 million5.26 millionNot OptionableNURONeuroMetrix202.06 million1.90 millionNot OptionableVTAKCatheter Precision148.84 million8.72 millionN/AVTAK, BSGM, NURO, and INBS HeadlinesRecent News About These CompaniesCatheter Precision to Attend and Participate in the 46th Heart Rhythm SocietyApril 24, 2025 | finance.yahoo.comCatheter Precision Acquires Late-Stage Heart Failure Therapy AssetsApril 23, 2025 | theglobeandmail.comCatheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart FailureApril 23, 2025 | finance.yahoo.comCatheter Precision, Inc. Announces Receipt of Audit Opinion with Going Concern DoubtApril 17, 2025 | quiverquant.comCatheter Precision Makes NYSE American Section 610(b) Public AnnouncementApril 17, 2025 | globenewswire.comCatheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product LineApril 14, 2025 | markets.businessinsider.comCatheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial ResultsMarch 28, 2025 | globenewswire.comCatheter Precision to Participate in and Share Data at Upcoming Industry ConferencesMarch 26, 2025 | markets.businessinsider.comFDA clears Imperative Care’s Symphony 16F 82cm catheterMarch 24, 2025 | massdevice.comCatheter Precision to Attend and Participate in the Western Atrial Fibrillation SymposiumFebruary 27, 2025 | markets.businessinsider.comCatheter Precision to attend, participate in ISLAAFebruary 11, 2025 | markets.businessinsider.comCatheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations StrategyFebruary 10, 2025 | globenewswire.comCatheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations StrategyFebruary 10, 2025 | prismmediawire.comCatheter Precision, Inc. to Showcase LockeT at 13th International Symposium on Left Atrial Appendage in Austin, TexasFebruary 6, 2025 | quiverquant.comCatheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial AppendageFebruary 6, 2025 | globenewswire.comCatheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLCFebruary 4, 2025 | markets.businessinsider.comCatheter Precision awards stock options to top executivesFebruary 4, 2025 | msn.comCatheter Precision Approves Executive Stock Option PlanFebruary 4, 2025 | tipranks.comCatheter Precision, Inc. Completes Acquisition of PeriKard, LLC to Enhance Ventricular Therapeutic Market OfferingsFebruary 4, 2025 | quiverquant.comCatheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLCFebruary 4, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVTAK, BSGM, NURO, and INBS Company DescriptionsBioSig Technologies NASDAQ:BSGM$0.92 +0.08 (+9.52%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$0.94 +0.02 (+1.63%) As of 04/25/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Intelligent Bio Solutions NASDAQ:INBS$1.29 -0.01 (-0.77%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$1.27 -0.02 (-1.16%) As of 04/25/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.NeuroMetrix NASDAQ:NURO$4.38 +0.00 (+0.00%) As of 04/25/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.Catheter Precision NYSEAMERICAN:VTAK$0.29 +0.01 (+1.76%) Closing price 04/25/2025 04:10 PM EasternExtended Trading$0.28 0.00 (-1.66%) As of 04/25/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
